{"success":true,"data":{"pressRelease":{"id":"165816","rtpr_id":"nPn3QDjCMa-20261009","ticker":"ALHC","exchange":"NASDAQ","all_tickers":["ALHC"],"title":"Alignment Healthcare Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Alignment Healthcare (ALHC)","author":"PR Newswire","published_at":"2026-10-09T22:51:00.031Z","article_body":"Alignment Healthcare Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Alignment Healthcare (ALHC)\nPR Newswire\n\nNEW YORK, Oct. 9, 2026\n\nTwo Wall Street downgrades followed CMS's 3.5-star 2027 rating for the\nAlignment Healthcare contract covering more than 75% of its health-plan\nmembers. ALHC opened to a roughly 20% decline, and an investigation into\npotential securities law violations is underway.\n\nNEW YORK, Oct. 9, 2026 /PRNewswire/ -- Alignment Healthcare, Inc. (NASDAQ:\nALHC) shares opened down roughly 20% on October 9, 2026, after the Centers for\nMedicare & Medicaid Services (CMS) released its 2027 Medicare Advantage\nStar Ratings, lowering the Company's California H3815 HMO contract to 3.5\nstars from 4.0 stars. If you held ALHC shares when the ratings landed and lost\nmoney, you may have legal rights. Investors who suffered losses are\nencouraged to submit their ALHC loss details now\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4793911-1&h=27269882&u=https%3A%2F%2Fsuewallst.com%2Finvestigations%2Falignment-healthcare-inc-investigation-alhc%3Fprid%3D211814%26wire%3D4&a=submit+their+ALHC+loss+details+now)\n. You may also contact Joseph E. Levi, Esq. via email at jlevi@SueWallSt.com\n(mailto:jlevi@SueWallSt.com)  or by telephone at (888) SueWallSt.\n\nAlignment's October 8 announcement reported that six of its seven eligible\ncontracts earned four stars or higher. The seventh contract, H3815, covers\nmore than 75% of its health-plan members and slipped from 4.0 to 3.5 stars.\nReportedly, following the news, Bank of America and William Blair both cut\ntheir price targets and downgraded to neutral / market perform positions, with\nthe latter cutting their price target by more than 60%.\n\nPreviously, during the Company's most recent earnings call on July 30, 2026,\nCEO John E. Kao indicated that, despite the \"shaky\" \"regulatory and legal\nfooting\" surrounding stars, he \"felt good about [Alignment's] position.\"\nAdditionally, Alignment's share price had previously faltered on September 15,\n2026, following comments at a Baird conference where CEO Kao reportedly\nrefused to comment on the pending star rating decisions: \"I cannot talk about\nit at all … we do not want to be the one poking the bear.\"\n\nShareholders who lost money as ALHC repriced can share their trading losses\nwith our team\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4793911-1&h=2069425304&u=https%3A%2F%2Fsuewallst.com%2Finvestigations%2Falignment-healthcare-inc-investigation-alhc%3Fprid%3D211814%26wire%3D4&a=share+their+trading+losses+with+our+team)\n or call (888) SueWallSt.\n\nWHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi &\nKorsinsky LLP has established itself as a nationally-recognized securities\nlitigation firm that has secured hundreds of millions of dollars for aggrieved\nshareholders and built a track record of winning high-stakes cases. The firm\nhas extensive expertise representing investors in complex securities\nlitigation and a team of over 70 employees to serve our clients. For seven\nyears in a row, Levi & Korsinsky has ranked in ISS Securities Class Action\nServices' Top 50 Report as one of the top securities litigation firms in the\nUnited States.\n\nFrequently Asked Questions About the ALHC Investigation\n\nQ: How much did ALHC stock drop?A: Shares fell from a closing price of $8.71\non October 8, 2026, to an opening price of just $6.95 the following morning,\nan overnight decline of roughly $1.76 per share, or about 20%. Investors who\npurchased shares at allegedly inflated prices and suffered losses may be\neligible to seek compensation.\n\nQ: When did Alignment Healthcare allegedly mislead investors?A: The\ninvestigation concerns statements made before the October 8, 2026 disclosure\nof the 2027 Star Ratings. Those statements allegedly caused investors to\npurchase ALHC securities at inflated prices.\n\nQ: Who is eligible to participate in the ALHC investigation?A: Investors who\npurchased ALHC stock or securities and suffered financial losses may be\neligible. Eligibility is based on purchase date and documented losses -- not\non whether you still hold the shares.\n\nQ: What do ALHC investors need to do right now?A: Investors may gather\nbrokerage records showing purchase dates, share quantities, and prices paid.\nSubmit your information for a no-cost, no-obligation evaluation of your\npotential recovery\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4793911-1&h=299354639&u=https%3A%2F%2Fsuewallst.com%2Finvestigations%2Falignment-healthcare-inc-investigation-alhc%3Fprid%3D211814%26wire%3D4&a=Submit+your+information+for+a+no-cost%2C+no-obligation+evaluation+of+your+potential+recovery)\n. No immediate action is required to remain eligible to participate in the\ninvestigation.\n\nQ: What documents do I need to participate?A: Brokerage statements or trade\nconfirmations showing purchase dates, share quantities, prices paid, and any\nsubsequent sale dates and prices.\n\nQ: What if I already sold my ALHC shares -- can I still recover losses?A: Yes.\nEligibility is based on when you purchased, not whether you still hold the\nshares. Investors who bought ALHC and sold at a loss may still participate in\nthe investigation.\n\nQ: What does it cost me to participate?A: There is no upfront cost to submit\nyour information and review whether you may be eligible to recover. Should you\nchoose to participate in any resulting action, these matters are generally\nhandled on a contingency basis. Any attorneys' fees and expenses are subject\nto court approval.\n\nQ: Do I need to go to court or give testimony?A: No. Participating in the\ninvestigation does not require court appearances or depositions. If legal\naction is later pursued, the overwhelming majority of affected investors never\nappear in court either.\n\nCONTACT:\n\nLevi & Korsinsky, LLP\n\nJoseph E. Levi, Esq.\n\n33 Whitehall Street, 27th Floor\n\nNew York, NY 10004\n\njlevi@SueWallSt.com (mailto:jlevi@SueWallSt.com)\n\nTel: (888) SueWallSt\n\nFax: (212) 363-7171\n\nAttorney Advertising. Prior results do not guarantee similar outcomes.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/alignment-healthcare-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-alignment-healthcare-alhc-302903843.html\n(https://www.prnewswire.com/news-releases/alignment-healthcare-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-alignment-healthcare-alhc-302903843.html)\n\nSOURCE SueWallSt.com\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1812443/suewallst-logo-1-Logo.jpg?id=OA2998584\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn3QDjCMa-20261009","title":"Alignment Healthcare Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Alignment Healthcare (ALHC)","author":"PR Newswire","ticker":"ALHC","created":"2026-10-09T22:51:00.031Z","tickers":["ALHC"],"exchange":"NASDAQ","article_body":"Alignment Healthcare Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Alignment Healthcare (ALHC)\nPR Newswire\n\nNEW YORK, Oct. 9, 2026\n\nTwo Wall Street downgrades followed CMS's 3.5-star 2027 rating for the\nAlignment Healthcare contract covering more than 75% of its health-plan\nmembers. ALHC opened to a roughly 20% decline, and an investigation into\npotential securities law violations is underway.\n\nNEW YORK, Oct. 9, 2026 /PRNewswire/ -- Alignment Healthcare, Inc. (NASDAQ:\nALHC) shares opened down roughly 20% on October 9, 2026, after the Centers for\nMedicare & Medicaid Services (CMS) released its 2027 Medicare Advantage\nStar Ratings, lowering the Company's California H3815 HMO contract to 3.5\nstars from 4.0 stars. If you held ALHC shares when the ratings landed and lost\nmoney, you may have legal rights. Investors who suffered losses are\nencouraged to submit their ALHC loss details now\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4793911-1&h=27269882&u=https%3A%2F%2Fsuewallst.com%2Finvestigations%2Falignment-healthcare-inc-investigation-alhc%3Fprid%3D211814%26wire%3D4&a=submit+their+ALHC+loss+details+now)\n. You may also contact Joseph E. Levi, Esq. via email at jlevi@SueWallSt.com\n(mailto:jlevi@SueWallSt.com)  or by telephone at (888) SueWallSt.\n\nAlignment's October 8 announcement reported that six of its seven eligible\ncontracts earned four stars or higher. The seventh contract, H3815, covers\nmore than 75% of its health-plan members and slipped from 4.0 to 3.5 stars.\nReportedly, following the news, Bank of America and William Blair both cut\ntheir price targets and downgraded to neutral / market perform positions, with\nthe latter cutting their price target by more than 60%.\n\nPreviously, during the Company's most recent earnings call on July 30, 2026,\nCEO John E. Kao indicated that, despite the \"shaky\" \"regulatory and legal\nfooting\" surrounding stars, he \"felt good about [Alignment's] position.\"\nAdditionally, Alignment's share price had previously faltered on September 15,\n2026, following comments at a Baird conference where CEO Kao reportedly\nrefused to comment on the pending star rating decisions: \"I cannot talk about\nit at all … we do not want to be the one poking the bear.\"\n\nShareholders who lost money as ALHC repriced can share their trading losses\nwith our team\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4793911-1&h=2069425304&u=https%3A%2F%2Fsuewallst.com%2Finvestigations%2Falignment-healthcare-inc-investigation-alhc%3Fprid%3D211814%26wire%3D4&a=share+their+trading+losses+with+our+team)\n or call (888) SueWallSt.\n\nWHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi &\nKorsinsky LLP has established itself as a nationally-recognized securities\nlitigation firm that has secured hundreds of millions of dollars for aggrieved\nshareholders and built a track record of winning high-stakes cases. The firm\nhas extensive expertise representing investors in complex securities\nlitigation and a team of over 70 employees to serve our clients. For seven\nyears in a row, Levi & Korsinsky has ranked in ISS Securities Class Action\nServices' Top 50 Report as one of the top securities litigation firms in the\nUnited States.\n\nFrequently Asked Questions About the ALHC Investigation\n\nQ: How much did ALHC stock drop?A: Shares fell from a closing price of $8.71\non October 8, 2026, to an opening price of just $6.95 the following morning,\nan overnight decline of roughly $1.76 per share, or about 20%. Investors who\npurchased shares at allegedly inflated prices and suffered losses may be\neligible to seek compensation.\n\nQ: When did Alignment Healthcare allegedly mislead investors?A: The\ninvestigation concerns statements made before the October 8, 2026 disclosure\nof the 2027 Star Ratings. Those statements allegedly caused investors to\npurchase ALHC securities at inflated prices.\n\nQ: Who is eligible to participate in the ALHC investigation?A: Investors who\npurchased ALHC stock or securities and suffered financial losses may be\neligible. Eligibility is based on purchase date and documented losses -- not\non whether you still hold the shares.\n\nQ: What do ALHC investors need to do right now?A: Investors may gather\nbrokerage records showing purchase dates, share quantities, and prices paid.\nSubmit your information for a no-cost, no-obligation evaluation of your\npotential recovery\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4793911-1&h=299354639&u=https%3A%2F%2Fsuewallst.com%2Finvestigations%2Falignment-healthcare-inc-investigation-alhc%3Fprid%3D211814%26wire%3D4&a=Submit+your+information+for+a+no-cost%2C+no-obligation+evaluation+of+your+potential+recovery)\n. No immediate action is required to remain eligible to participate in the\ninvestigation.\n\nQ: What documents do I need to participate?A: Brokerage statements or trade\nconfirmations showing purchase dates, share quantities, prices paid, and any\nsubsequent sale dates and prices.\n\nQ: What if I already sold my ALHC shares -- can I still recover losses?A: Yes.\nEligibility is based on when you purchased, not whether you still hold the\nshares. Investors who bought ALHC and sold at a loss may still participate in\nthe investigation.\n\nQ: What does it cost me to participate?A: There is no upfront cost to submit\nyour information and review whether you may be eligible to recover. Should you\nchoose to participate in any resulting action, these matters are generally\nhandled on a contingency basis. Any attorneys' fees and expenses are subject\nto court approval.\n\nQ: Do I need to go to court or give testimony?A: No. Participating in the\ninvestigation does not require court appearances or depositions. If legal\naction is later pursued, the overwhelming majority of affected investors never\nappear in court either.\n\nCONTACT:\n\nLevi & Korsinsky, LLP\n\nJoseph E. Levi, Esq.\n\n33 Whitehall Street, 27th Floor\n\nNew York, NY 10004\n\njlevi@SueWallSt.com (mailto:jlevi@SueWallSt.com)\n\nTel: (888) SueWallSt\n\nFax: (212) 363-7171\n\nAttorney Advertising. Prior results do not guarantee similar outcomes.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/alignment-healthcare-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-alignment-healthcare-alhc-302903843.html\n(https://www.prnewswire.com/news-releases/alignment-healthcare-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-alignment-healthcare-alhc-302903843.html)\n\nSOURCE SueWallSt.com\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1812443/suewallst-logo-1-Logo.jpg?id=OA2998584\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-10-09T22:51:00.077232848Z","server_sent_at_ms":1791586260077},"received_at":"2026-10-09T22:51:00.128Z","source_url":"https://www.prnewswire.com/news-releases/alignment-healthcare-investigation-notice-suewallst-notifies-investors-of-pending-investigation-into-alignment-healthcare-alhc-302903843.html"},"analysis":{"id":"154200","press_release_id":"165816","analysis_json":{"industry":{"label":"Health Care Providers & Services","sector":"Health Care"},"redFlags":["CMS star-rating downgrade on contract covering >75% of members — material 2027 revenue/rebate risk","Two analyst downgrades including a >60% price-target cut","Securities investigation into pre-disclosure statements; CEO previously called stars footing 'shaky'"],"eventType":"legal_litigation","narrative":"SueWallSt (Levi & Korsinsky) announced an investigation into potential securities law violations at Alignment Healthcare, soliciting investors who lost money after the stock's roughly 20% drop on October 9, 2026.\n\nThe drop followed CMS cutting ALHC's H3815 California contract — covering more than 75% of members — from 4.0 to 3.5 stars in the 2027 Star Ratings, prompting downgrades from Bank of America and William Blair, with William Blair cutting its target by more than 60%.\n\nThe release is law-firm marketing rather than an issuer disclosure; the substantive catalyst (the CMS star downgrade) is the material event, not the investigation itself.","sentiment":"bearish","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation — suppress; watch for issuer response on the CMS star downgrade instead."},"keyFigures":{"customDimensions":{"star_rating_change":"H3815 contract downgraded to 3.5 stars from 4.0","share_of_members_in_affected_contract":">75%"}},"quotedText":"shares opened down roughly 20% on October 9, 2026, after the Centers for Medicare & Medicaid Services (CMS) released its 2027 Medicare Advantage Star Ratings, lowering the Company's California H3815 HMO contract to 3.5 stars from 4.0 stars","namedEntities":{"people":[{"name":"Joseph E. Levi, Esq.","role":"attorney, Levi & Korsinsky"},{"name":"John E. Kao","role":"CEO of Alignment Healthcare"}],"products":["H3815 California HMO contract","2027 Medicare Advantage Star Ratings"],"companies":[{"name":"Alignment Healthcare, Inc.","ticker":"ALHC","relationship":"investigation target"},{"name":"SueWallSt (Levi & Korsinsky LLP)","relationship":"plaintiff law firm"},{"name":"Bank of America","relationship":"analyst (downgraded ALHC)"},{"name":"William Blair","relationship":"analyst (downgraded ALHC)"},{"name":"Centers for Medicare & Medicaid Services (CMS)","relationship":"regulator"}],"dollarAmounts":[{"amount":"$8.71","context":"ALHC close on October 8, 2026"},{"amount":"$6.95","context":"ALHC opening price October 9, 2026"},{"amount":"$1.76","context":"overnight per-share decline"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm solicitation by SueWallSt/Levi & Korsinsky seeking investor loss submissions. No court action, certified class, or settlement; underlying stock drop already occurred."},"tickerRelevance":{"others":[],"primary":"ALHC"},"globalImportance":18,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false,"underlyingCatalyst":"CMS star downgrade drove ~20% stock drop"}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"bearish","material_impact_score":1,"narrative":"SueWallSt (Levi & Korsinsky) announced an investigation into potential securities law violations at Alignment Healthcare, soliciting investors who lost money after the stock's roughly 20% drop on October 9, 2026.\n\nThe drop followed CMS cutting ALHC's H3815 California contract — covering more than 75% of members — from 4.0 to 3.5 stars in the 2027 Star Ratings, prompting downgrades from Bank of America and William Blair, with William Blair cutting its target by more than 60%.\n\nThe release is law-firm marketing rather than an issuer disclosure; the substantive catalyst (the CMS star downgrade) is the material event, not the investigation itself.","key_figures":{"customDimensions":{"star_rating_change":"H3815 contract downgraded to 3.5 stars from 4.0","share_of_members_in_affected_contract":">75%"}},"named_entities":{"people":[{"name":"Joseph E. Levi, Esq.","role":"attorney, Levi & Korsinsky"},{"name":"John E. Kao","role":"CEO of Alignment Healthcare"}],"products":["H3815 California HMO contract","2027 Medicare Advantage Star Ratings"],"companies":[{"name":"Alignment Healthcare, Inc.","ticker":"ALHC","relationship":"investigation target"},{"name":"SueWallSt (Levi & Korsinsky LLP)","relationship":"plaintiff law firm"},{"name":"Bank of America","relationship":"analyst (downgraded ALHC)"},{"name":"William Blair","relationship":"analyst (downgraded ALHC)"},{"name":"Centers for Medicare & Medicaid Services (CMS)","relationship":"regulator"}],"dollarAmounts":[{"amount":"$8.71","context":"ALHC close on October 8, 2026"},{"amount":"$6.95","context":"ALHC opening price October 9, 2026"},{"amount":"$1.76","context":"overnight per-share decline"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-09T22:51:05.358Z","global_importance":18,"audience_relevance":15,"importance_components":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false,"underlyingCatalyst":"CMS star downgrade drove ~20% stock drop"}},"durationMs":5202,"modelName":"glm-5.3-flashx"}}